CAR T cell therapy-related lumbosacral polyradiculopathy with myelitis and stiff person syndrome with response to intravenous immunoglobulin and corticosteroids in a patient with acute lymphoblastic leukemia

QR Code

CAR T cell therapy-related lumbosacral polyradiculopathy with myelitis and stiff person syndrome with response to intravenous immunoglobulin and corticosteroids in a patient with acute lymphoblastic leukemia

Saved in:

Bibliographic Details
Main Authors:	Hannah Goulart, Kevin Elmore, Stephen Scelsa, Daniel Park, Alla Keyzner, Uroosa Ibrahim
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137925002007
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

POLYRADICULOPATHY FOLLOWING CAR T-CELL THERAPY FOR LYMPHOID MALIGNANCIES, DIAGNOSTIC CHALLENGES: A REPORT OF 3 CASES
by: Alfadil Haroon, et al.
Published: (2025-07-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRICS
by: A.Yu. Shcherbina, et al.
Published: (2010-07-01)

IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015-04-01)

Use of Intravenous Immunoglobulins in Intensive Therapy
by: E. A. Latysheva, et al.
Published: (2012-06-01)

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE
by: T. V. Latysheva, et al.
Published: (2013-01-01)

The place of intravenous immunoglobulin in rheumatic diseases
by: N. V. Seredavkina, et al.
Published: (2016-01-01)

Intravenous Immunoglobulin Therapy in Primary Vasculitides
by: Lukán, Norbert
Published: (2011)

INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
by: V. A. Lazanovich, et al.
Published: (2014-08-01)

Use of intravenous immunoglobulins in clinical practice
by: E.K. Donyush
Published: (2011-03-01)

SPECIFIC IMMUNOGLOBULINS FOR INTRAVENOUS INJECTION IN PEDIATRIC PRACTICES
by: A.L. Zaplatnikov
Published: (2007-02-01)

RATIONAL APPLICATION OF HUMAN NORMAL IMMUNOGLOBULIN FOR THE INTRAVENOUS INDUCTION
by: I.D. Fesenko
Published: (2007-02-01)

Intravenous immunoglobulin: prospects in patients with autoimmune rheumatic diseases
by: Elena Aleksandrovna Aseeva, et al.
Published: (2014-03-01)

Peculiar features of intravenous immunoglobulins application in rheumatic diseases
by: O. N. Egorova, et al.
Published: (2024-06-01)

Lumbosacral motor polyneuropathy
by: S. A. Malmberg, et al.
Published: (2015-02-01)

Intravenous Immunoglobulins in Neurological Diseases: Established and Novel Clinical Applications
by: Yiannopoulou, Konstantina G.
Published: (2011)

Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
by: E. S. Orlova, et al.
Published: (2025-01-01)

HAEMAGGLUTINATION TECHNIQUES TO EVALUATE SPECIFIC SAFETY OF HUMAN INTRAVENOUS IMMUNOGLOBULINS
by: O. G. Kornilova, et al.
Published: (2017-10-01)

Possibility to Obtain Anti-Athrax Human Immunoglobulin for Intravenous Injection
by: V. Yu. Dolmatov, et al.
Published: (2008-04-01)

EFFICACY OF INTRAVENOUS IMMUNOGLOBULINS IN COMPLEX TREATMENT OF PERINATAL INFECTIONS IN PRETERM NEONATES
by: V.A. Bushtyriev, et al.
Published: (2006-03-01)

Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin
by: A. M. Nikolaeva, et al.
Published: (2023-02-01)

Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin
by: Megan E. McNamara, PhD, et al.
Published: (2025-08-01)

EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01)

Immunomodulatory Treatments for Myasthenia Gravis: Plasma Exchange, Intravenous Immunoglobulins and Semiselective Immunoadsorption
by: Baggi, Fulvio, et al.
Published: (2012)

Adverse Reactions to Intravenous Immunoglobulin Therapy: An Analysis of the Russian National Pharmacovigilance Database
by: A. V. Nechaev, et al.
Published: (2024-12-01)

Efficacy of Intravenous Immunoglobulins and Other Immunotherapies in Neurological Disorders and Immunological Mechanisms Involved
by: Angel Justiz-Vaillant, et al.
Published: (2025-05-01)

The effectiveness of chondroprotective therapy in patients with lumbosacral dorsopathies
by: N. V. Yakovleva, et al.
Published: (2021-06-01)

INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION FOR DESENSITIZATION BEFORE RENAL TRANSPLANTATION AND MANAGING ANTIBODY-MEDIATED REJECTION
by: A. I. Sushkov, et al.
Published: (2011-06-01)

USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
by: M. I. Krivonos, et al.
Published: (2017-12-01)

CLINICAL LABORATORY INDICATORS OF PREGNANT WITH ANTIPHOSPHOLIPID SYNDROME IN COMPLEX THERAPY WITH USING INTRAVENOUS IMMUNOGLOBULIN
by: V. I. Linnikov
Published: (2016-06-01)

Treatment with intravenous immunoglobulin modulates coagulation- and complement-related pathways in COVID-19 patients
by: Dominic McGrosso, et al.
Published: (2025-07-01)

Clinical prediction of intravenous immunoglobulin-resistant Kawasaki disease based on interpretable Transformer model
by: Gahao Chen, et al.
Published: (2025-01-01)

Clinical prediction of intravenous immunoglobulin-resistant Kawasaki disease based on interpretable Transformer model.
by: Gahao Chen, et al.
Published: (2025-01-01)

Application of multi-targeted CAR-T cell therapy in B-cell acute lymphoblastic leukemia
by: CAO Jinjin, DU Juan, QU Shanna, ZHU Mingyu, WANG Yang, HU Han, LIU Binlei
Published: (2025-05-01)

Nonspecific pain in the lumbosacral area: clinical features of and approachesto drug therapy (according to the materials of the European guidelinesfor the management of nonspecific lumbosacral pain)
by: Tat'yana Alekseevna Raskina, et al.
Published: (2011-06-01)

Best practices in the use of human immunoglobulin preparations for intravenous administration in the treatment of rare neurological diseases
by: N. M. Tereshchenko, et al.
Published: (2023-04-01)

Intravenous immunoglobulins and recombinant granulocyte-colony stimulating factor modulate expression of NK cytotoxic receptors
by: A. A. Davydova, et al.
Published: (2024-11-01)

Determination of optimum nanofiltration conditions for the manufacturing process of human normal immunoglobulin G for intravenous administration
by: N. V. Zubkova, et al.
Published: (2023-10-01)

Clinical polymorphism of myelitis in neurologic practice. Lecture with description of clinical cases
by: A. A. Kondratov, et al.
Published: (2024-07-01)

Longitudinal extensive transverse myelitis as the initial manifestation of the acquired immunodeficiency syndrome
by: Ana María Jiménez Echavarría, et al.
Published: (2025-07-01)